Trial Profile

A randomized, multicenter, open-label Phase III study evaluating BAT8006 versus investigator's choice of chemotherapy in subjects with platinum-resistant advanced ovarian cancer, primary peritoneal cancer, and fallopian tube cancer

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 02 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

02 Jul 2025 New trial record
25 Jun 2025 According to Bio Thera Solutions media release, company announced that dosing has begun in a phase 3 clinical study for BAT8006, an antibody drug conjugate targeting folate receptor alpha for the treatment of platinum resistant ovarian cancer.
25 Jun 2025 Status changed from not yet recruiting to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com